Jarem Edwards

2.8k citations

18 papers · 1.5k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Immunology 13
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 2
Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 6
- Cytokine Signaling Pathways and Interactions 2

Co-authors: James S. Wilmott Richard A. Scolyer Georgina V. Long Alexander M. Menzies Shahneen Sandhu Victoria Atkinson Michael P. Brown Grant A. McArthur
Journals: Clinical Cancer Research (2 papers)International Journal of Cancer (2 papers)Journal of Autoimmunity (1 paper)Nature Communications (1 paper)Data in Brief (1 paper)
Partner nations: Australia United States Singapore

In The Last Decade

Jarem Edwards

17 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study 2018 · 655 citations

Peers

Countries citing papers authored by Jarem Edwards

Since Specialization

Citations

This map shows the geographic impact of Jarem Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarem Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarem Edwards more than expected).

Fields of papers citing papers by Jarem Edwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarem Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarem Edwards. The network helps show where Jarem Edwards may publish in the future.

Co-authors

The 25 scholars most cited alongside Jarem Edwards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jarem Edwards Line = papers co-authored together Jarem Edwards links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis The Journal of Experimental Medicine ·AdrianJ Lowe, Ellis Patrick, Jarem Edwards, James S. Wilmott, Vithyasaahar Sethumadhavan, 浦云峰, Daniel L. Barber, J. Ernst, Warwick J. Britton, Umaimainthan Palendira, Xinchun Chen, Carl G. Feng	2023	29
2	Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas Cancer Immunology Research ·Jarem Edwards, Peter M. Ferguson, Serigne Lo, Inês Pires da Silva, Andrew J. Colebatch, Hansol Lee, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Felicity Newell, John V. Pearson, Nicola Waddell, Nicholas K. Hayward, Peter A. Johansson, Graham J. Mann, Richard A. Scolyer, Umaimainthan Palendira, James S. Wilmott	2020	14
3	Abstract 913: Defining melanoma patients unresponsive to single agent anti-PD-1 therapy but responsive to combination anti-PD-1 + anti-CTLA-4 therapy Cancer Research ·Jarem Edwards, 陈洪宇, Angela L. Ferguson, Peter A. Johansson, 裕之太田, Grace H. Attrill, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, Georgina V. Long, Richard A. Scolyer, James S. Wilmott	2020	0
4	CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma Journal for ImmunoTherapy of Cancer ·Rehana Hewavisenti, Angela L. Ferguson, Kevin Wang, D. Brian Jones, Thomas Gebhardt, Jarem Edwards, Mei Zhang, Warwick J. Britton, Jean Yang, Angela Hong, Umaimainthan Palendira	2020	31
5	Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials Clinical Cancer Research ·Jarem Edwards, Annie Tasker, Inês Pires da Silva, Camelia Quek, Marcel Batten, Angela L. Ferguson, 石田真紗子, Sharan Kumar Gopasetty, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, James S. Wilmott, Georgina V. Long, Richard A. Scolyer	2019	26
6	LNK suppresses interferon signaling in melanoma Nature Communications ·Ling‐Wen Ding, Qiao‐Yang Sun, Jarem Edwards, Lucia Torres Fernández, 冨男吉田, Siqin Zhou, Richard A. Scolyer, James S. Wilmott, John F. Thompson, Ngan Doan, Jonathan Said, R. Menjón, Jin-Fen Xiao, 吴育志, Maren Pein, Liang Xu, David W. Mullins, Henry Yang, De‐Chen Lin, H. Phillip Koeffler	2019	20
7	Comprehensive molecular profiling of metastatic melanoma to predict response to monotherapy and combination immunotherapy. Journal of Clinical Oncology ·Athanasios Vafeidis, Alexander M. Menzies, Felicity Newell, James S. Wilmott, Matteo S. Carlino, Peter M. Ferguson, Jarem Edwards, Andrew J. Spillane, Kerwin F. Shannon, Robyn P.M. Saw, John F. Thompson, Helen Rizos, Graham J. Mann, Peter A. Johansson, Nicholas K. Hayward, Richard A. Scolyer, Nicola Waddell, Georgina V. Long	2019	2
8	CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment Clinical Cancer Research ·Jarem Edwards, James S. Wilmott, Jason Madore, Tuba N. Gide, Camelia Quek, Annie Tasker, Angela L. Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira	2018	317
9	Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study The Lancet Oncology ·Georgina V. Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander Guminski, Michael P. Brown, James S. Wilmott, Jarem Edwards, Maria Gonzalez, Richard A. Scolyer, Alexander M. Menzies, Grant A. McArthur Hit paper breakdown →	2018	655
10	Melanoma protective antitumor immunity activated by catalytic DNA Oncogene ·Hong Cai, Eunae Sandra Cho, Yue Li, 李玉玲, Christopher R. Parish, Beng H. Chong, Jarem Edwards, Tristan J. Dodds, Peter M. Ferguson, James S. Wilmott, Richard A. Scolyer, Gary M. Halliday, Levon M. Khachigian	2018	16
11	The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis Journal of Autoimmunity ·Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant P. Parnell, Stephen D. Schibeci, Jarem Edwards, Vargha, 喬大森, Marzena J. Fabis‐Pedrini, Allan G. Kermode, 守隆菅, Jacob L. McCauley, Dorothee Nickles, Sergio E. Baranzini, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	2017	23
12	Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis Data in Brief ·Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant P. Parnell, Stephen D. Schibeci, Jarem Edwards, Vargha, 喬大森, Marzena J. Fabis‐Pedrini, Allan G. Kermode, 守隆菅, Jacob L. McCauley, Dorothee Nickles, Sergio E. Baranzini, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	2017	5
13	Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report Cancer Immunology Immunotherapy ·Helen M. McGuire, Elena Shklovskaya, Jarem Edwards, Paul Trevillian, Geoffrey W. McCaughan, Patrick Bertolino, Catriona McKenzie, Ralph Gourlay, Stuart Gallagher, Barbara Fazekas de St Groth, Peter Hersey	2017	51
14	Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs PLoS Pathogens ·ბორის ჭიჭინაძე, Asolina Braun, Jane Li, Corey Smith, Jarem Edwards, Frédéric Sierro, Carl G. Feng, Rajiv Khanna, 一彦染谷, Andrew Bell, Andrew D. Hislop, Stuart G. Tangye, Alan B. Rickinson, Thomas Gebhardt, Warwick J. Britton, Umaimainthan Palendira	2016	73
15	Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. PubMed ·P. Mark Hogarth, Jarem Edwards, Ian F. C. McKenzie, James W. Goding, F Y Liew	1982	64
16	Characterization of mononuclear effector cells in human blood. PubMed ·Peter Hersey, A. Edwards, Jarem Edwards	1976	44
17	Comparison of ⁵¹Cr release and microcytotoxicity assays against human melanoma cells International Journal of Cancer ·Peter Hersey, Jarem Edwards, A. Edwards, E.P. Adams, 光順福田, G. W. Milton	1975	14
18	Specificity of cell‐mediated cytotoxicity against human melanoma lines: Evidence for “non‐specific” killing by activated T‐cells International Journal of Cancer ·Peter Hersey, A. Edwards, Jarem Edwards, E.P. Adams, G. W. Milton, Douglas S. Nelson	1975	94

About Jarem Edwards

Jarem Edwards is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers), T-cell and B-cell Immunology (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune Cell Function and Interaction (2 papers), Melanoma and MAPK Pathways (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Oncology (962 citations), Immunology (673 citations), Genetics (203 citations), Pulmonary and Respiratory Medicine (448 citations) and Molecular Biology (338 citations). Jarem Edwards has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, Shahneen Sandhu, Victoria Atkinson, Michael P. Brown, Grant A. McArthur, Alexander Guminski and Maria Gonzalez. Their work appears in journals such as Clinical Cancer Research, International Journal of Cancer, Journal of Autoimmunity, Nature Communications and Data in Brief.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact